The presence of particular criteria and non-criteria antiphospholipid antibodies in patients with uterine malignancies

• DOI: 10.20452/pamw.15624
• Publication Date: 2020-09-25T17:12:05Z
• Authors: Andrzej Majdan; Maria Majdan; Magdalena Dryglewska; Patrycja Ziober-M...; Jan Kotarski; Ludmiła Grzybowsk...
• Keywords: Uterine cancer; Thromboembolic disease

Antiphospholipid antibodies in uterine malignancies 1037 INTROduCTION Thrombosis is a common complication observed patients with malignancies. 1-3Several factors responsible for the development of thrombosis have been identified.Interactions between cancer cells, coagulation mechanisms, and immune system may play an essential role initiating thrombotic processes accompanying tumors. 4-9Women reproductive tract malignancies, including (UMs), are at high risk thromboembolic complications also because comorbidities, advanced clinical stage disease time diagnosis,